STIM 8-K 2026-11-04

Neuronetics, Inc. (STIM) 8-K dated 2026-11-04 — accession 0001193125-26-446239.

Neuronetics, Inc. (STIM) is a medical devices company listed on NASDAQ.

STIM: Neuronetics Reports Third Quarter 2026 Financial and Operating Results

This 8-K covers: Results of operations (Item 2.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported STIM revenue for 2025-12-31 was $149.2M. Net income was -$39.0M. Revenue was up 99.2% from 2024-12-31 to 2025-12-31. STIM currently screens at market cap $84.2M.

Not investment advice. The STIM SEC hub lists recent forms. The stock page is the research view.